What is the ticker symbol for NeuroPace?

NeuroPace trades under the ticker NPCE on NASDAQ.

What sector does NeuroPace operate in?

NeuroPace is classified in the Healthcare sector (Medical - Devices industry).

How can PortView help analyze NPCE in a portfolio?

PortView shows NPCE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

NeuroPace (NPCE) Stock Analysis

NASDAQHealthcareMedical - Devices

$15.10+2.43%

1-year price historyRange $9.36 – $19.29

52-week range$15.10

$8.88$19.60

What NeuroPace does

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Key metrics

Market cap

$514.74M

P/E (TTM)

-26.49

EPS (TTM)

$-0.57

Beta

1.94

Dividend yield

0.00%

Revenue / share

$2.90

50-day avg

$15.18

200-day avg

$15.45

52-week high

$19.60

52-week low

$8.88

CEO

Joel D. Becker

ETFs linked to NPCE

Broad-market and Healthcare sector ETFs an investor holding NeuroPace is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how NPCE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NPCE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for NeuroPace?: NeuroPace trades under the ticker NPCE on NASDAQ.
Which exchange is NPCE listed on?: NPCE is listed on NASDAQ.
What sector does NeuroPace operate in?: NeuroPace is classified in the Healthcare sector (Medical - Devices industry).
How can PortView help analyze NPCE in a portfolio?: PortView shows NPCE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.